Saudi Pharmaceutical (Saudi Arabia) Today

2070 Stock  SAR 23.00  0.02  0.09%   
Market Performance
0 of 100
Odds Of Distress
Less than 40
Saudi Pharmaceutical is selling at 23.00 as of the 6th of February 2023; that is -0.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 23.0. Saudi Pharmaceutical has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Saudi Pharmaceutical Appliances are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of February 2021 and ending today, the 6th of February 2023. Click here to learn more.
Fiscal Year End
December
Category
Healthcare
ISIN
SA0007879188
Saudi Pharmaceutical Industries Medical Appliances Corporation develops, manufactures, and markets medicinal products and pharmaceutical formulations, production supplies, medical equipment and supplies, basic and intermediary med petrochemicals and their derivatives in the Kingdom of Saudi Arabia and internationally. The company has 120 M outstanding shares. More on Saudi Pharmaceutical Appliances

Moving together with Saudi Pharmaceutical

+0.884164Nahdi MedicalPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Saudi Pharmaceutical Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Saudi Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Saudi Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Saudi Pharmaceutical generated a negative expected return over the last 90 days
About 34.0% of the company shares are owned by insiders or employees
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Saudi Pharmaceutical's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldOvervalued
Saudi Pharmaceutical Appliances (2070) is traded on Saudi Arabia Exchange in Saudi Arabia and employs 10 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.76 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Saudi Pharmaceutical's market, we take the total number of its shares issued and multiply it by Saudi Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Saudi Pharmaceutical operates under Healthcare sector and is part of Biotechnology industry. The entity has 120 M outstanding shares. Saudi Pharmaceutical Appliances has accumulated about 231.07 M in cash with 86.71 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.93.
Check Saudi Pharmaceutical Probability Of Bankruptcy
Ownership
Saudi Pharmaceutical shows a total of one hundred twenty million outstanding shares. Saudi Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Saudi Ownership Details

Saudi Stock Price Odds Analysis

In regard to a normal probability distribution, the odds of Saudi Pharmaceutical jumping above the current price in 90 days from now is about 70.44%. The Saudi Pharmaceutical Appliances probability density function shows the probability of Saudi Pharmaceutical stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Saudi Pharmaceutical Appliances has a beta of -0.1151. This suggests as returns on benchmark increase, returns on holding Saudi Pharmaceutical are expected to decrease at a much lower rate. During the bear market, however, Saudi Pharmaceutical Appliances is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Saudi Pharmaceutical is significantly underperforming NYSE Composite.
  Odds Below 23.0HorizonTargetOdds Above 23.0
29.40%90 days
 23.00 
70.44%
Based on a normal probability distribution, the odds of Saudi Pharmaceutical to move above the current price in 90 days from now is about 70.44 (This Saudi Pharmaceutical Appliances probability density function shows the probability of Saudi Stock to fall within a particular range of prices over 90 days) .

Saudi Pharmaceutical Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Saudi Pharmaceutical market risk premium is the additional return an investor will receive from holding Saudi Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Saudi Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Saudi Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Saudi Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.

Saudi Stock Against Markets

Picking the right benchmark for Saudi Pharmaceutical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Saudi Pharmaceutical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Saudi Pharmaceutical is critical whether you are bullish or bearish towards Saudi Pharmaceutical Appliances at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Saudi Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Saudi Pharmaceutical Corporate Management

Elected by the shareholders, the Saudi Pharmaceutical's board of directors comprises two types of representatives: Saudi Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saudi. The board's role is to monitor Saudi Pharmaceutical's management team and ensure that shareholders' interests are well served. Saudi Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saudi Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Engineer AlAkel - Ex InvestmentProfile
Abdulrahman Kabbani - Head ComplianceProfile
Mohammed AlFadhli - VP MarketingProfile
Amjad Ali - Chief OfficerProfile
Michael Baum - Chief OfficerProfile
Maged Taha - Chief OfficerProfile
HE AlKhattaf - Chief OfficerProfile

Invested in Saudi Pharmaceutical Appliances?

The danger of trading Saudi Pharmaceutical Appliances is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Saudi Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Saudi Pharmaceutical. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Saudi Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for analysis

When running Saudi Pharmaceutical price analysis, check to measure Saudi Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Saudi Pharmaceutical is operating at the current time. Most of Saudi Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Saudi Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Saudi Pharmaceutical's price. Additionally, you may evaluate how the addition of Saudi Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Please note, there is a significant difference between Saudi Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Saudi Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Saudi Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.